1. US FDA. Final report, pharmaceutical CGMPs for the 21st century – a risk-based approach. 2004. Available at: https://www.USFDA.gov/media/77391/download. Accessed 10 January 2024.
2. US FDA. Final Report FDA-EMA pilot program for the parallel assessment of quality-by-design elements of marketing applications. 2007. Available at:https://www.USFDA.gov/drugs/pharmaceutical-quality-resources/final-report-USFDA-ema-pilot-program-parallel-assessment-quality-design-elements-marketing. Accessed 10 January 2024.
3. International Committee for Harmonization. Guideline database. Available at: https://ich.org/.
4. International Committee for Harmonization. Quality guidelines. Available at: https://ich.org/page/quality-guidelines. Accessed 10 January 2024.
5. International Committee for Harmonization. Q8(R2): pharmaceutical development. 2009. Available at: https://database.ich.org/sites/default/files/Q8_R2_Guideline.pdf.